FDA Authorizes Johnson & Johnson's OTTAVA Robotic Surgical System

Johnson & Johnson has secured De Novo authorization from the FDA for its innovative OTTAVA Robotic Surgical System. This system, noted for being the first table-integrated soft tissue robotic platform, is now cleared for marketing for a range of general surgical procedures, including gastric, gallbladder, and hernia operations.